Target Price | $9.00 |
Price | $1.95 |
Potential |
361.54%
register free of charge
|
Number of Estimates | 1 |
1 Analyst has issued a Aytu BioScience Inc price target 2026.
The average Aytu BioScience Inc target price is $9.00.
This is
361.54%
register free of charge
|
|
A rating was issued by 1 analysts: 1 Analysts recommend Aytu BioScience Inc to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Aytu BioScience Inc stock has an average upside potential 2026 of
361.54%
register free of charge
|
Jun '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 81.00 | 70.85 |
24.58% | 12.53% | |
EBITDA Margin | 2.86% | 19.59% |
146.61% | 583.96% | |
Net Margin | -19.56% | 5.75% |
22.82% | 129.40% |
1 Analyst has issued a sales forecast Aytu BioScience Inc 2025 . The average Aytu BioScience Inc sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued an EBITDA forecast Aytu BioScience Inc 2025 . The average Aytu BioScience Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
1 Analyst has issued a net profit forecast Aytu BioScience Inc 2025 . The average Aytu BioScience Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Jun '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -2.86 | 0.66 |
44.79% | 123.08% | |
P/E | 2.95 | |
EV/Sales | 0.22 |
1 Analysts have issued a Aytu BioScience Inc forecast for earnings per share. The average Aytu BioScience Inc EPS is
This results in the following potential growth metrics and future valuations:
Aytu BioScience Inc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.